Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2015

Elevated Farnesoid X Receptor (FXR) and Retinoid X Receptors (RXRs) expression is associated with less tumor aggressiveness and favourable prognosis in patients with pancreatic adenocarcinoma
Authors: C. GIAGINIS, I. KOUTSOUNAS, P. ALEXANDROU, A. ZIZI-SERBETZOGLOU, E. PATSOURIS, G. KOURAKLIS, S. THEOCHARIS
Neoplasma Vol.62, No.2, p.332-341, 2015
doi:10.4149/neo_2015_040
Price: free access
[View Abstract]


Daily image-guidance in prostate cancer radiotherapy – implications for treatment margins
Authors: G. GLOWACKI, W. MAJEWSKI, P. WOJCIESZEK, A. TUKIENDORF, D. BODUSZ, G. WOZNIAK, L. MISZCZYK
Neoplasma Vol.62, No.2, p.326-331, 2015
doi:10.4149/neo_2015_039
Price: free access
[View Abstract]


Assessing the interactions between the associations of common genetic variants on 2q35 and 16q12 with breast cancer risk
Authors: Y. L. FAN, Z. J. GUO, P. ZHU, X. J. YANG, X. D. YANG, B. YU, L. H. LI
Neoplasma Vol.62, No.2, p.315-325, 2015
doi:10.4149/neo_2015_038
Price: free access
[View Abstract]


Impact of risk factors on prevalence of anal HPV infection in women with simultaneous cervical lesion
Authors: J. SLAMA, B. SEHNAL, L. DUSEK, T. ZIMA, D. CIBULA
Neoplasma Vol.62, No.2, p.308-314, 2015
doi:10.4149/neo_2015_037
Price: free access
[View Abstract]


Gefitinib maintenance therapy in Chinese advanced-stage lung adenocarcinoma patients with EGFR mutations treated with prior chemotherapy
Authors: K. C. CAI, D. G. LIU, Y. Y. WANG, H. WU, Z. Y. HUANG, R. J. CAI, H. F. WANG, G. XIONG, Z. L. ZHANG
Neoplasma Vol.62, No.2, p.302-307, 2015
doi:10.4149/neo_2015_036
Price: free access
[View Abstract]


Comparison of 18F-FDG PET/CT and MDCT for staging/restaging of non-small cell lung cancer
Authors: D. SOBIC-SARANOVIC, I. PETRUSIC, V. ARTIKO, S. PAVLOVIC, D. SUBOTIC, D. SARANOVIC, L. NAGORNI-OBRADOVIC, N. PETROVIC, M. TODOROVIC-TIRNANIC, S. ODALOVIC, I. GROZDIC-MILOJEVIC, M. STOILJKOVIC, V. OBRADOVIC
Neoplasma Vol.62, No.2, p.295-301, 2015
doi:10.4149/neo_2015_035
Price: free access
[View Abstract]


Decreased bone mineral density and alteration in biochemical bone metabolism markers in children affected by bone tumors after completion of therapy
Authors: J. AMBROSZKIEWICZ, J. GAJEWSKA, E. ROGOWSKA, K. SZAMOTULSKA, M. CHELCHOWSKA, G. ROWICKA, M. RYCHLOWSKA-PRUSZYNSKA
Neoplasma Vol.62, No.2, p.288-294, 2015
doi:10.4149/neo_2015_034
Price: free access
[View Abstract]


Clinical significance of ERG rearrangement subtype and its association with increased p53 expression in Japanese and German prostate cancer
Authors: J. NISHIJIMA, T. HARA, K. IKEMOTO, A. OGA, K. KOBAYASHI, Y. KAWAI, H. MATSUMOTO, K. NAGAO, K. SASAKI, V. GKOLEIZAKIS, J. FICHTNER, H. MATSUYAMA
Neoplasma Vol.62, No.2, p.278-287, 2015
doi:10.4149/neo_2015_033
Price: free access
[View Abstract]


MR-mammography – impact on disease extent determination and surgical treatment of invasive ductal and lobular breast cancers
Authors: V. LEHOTSKA, K. RAUOVA, L. VANOVCANOVA 
Neoplasma Vol.62, No.2, p.269-277, 2015
doi:10.4149/neo_2015_032
Price: free access
[View Abstract]


Predictive factors for the presence of tumor cells in bone marrow and peripheral blood in breast cancer patients
Authors: M. Cabinakova, V. Mikulova, K. Malickova, D. Vrana, D. Pavlista, L. Petruzelka, T. Zima, P. Tesarova
Neoplasma Vol.62, No.2, p.259-268, 2015
doi:10.4149/neo_2015_031
Price: free access
[View Abstract]


Clinical significance of microRNA-24 expression in esophageal squamous cell carcinoma
Authors: W. DONG, B. LI, Z. WANG, Z. ZHANG, J. WANG
Neoplasma Vol.62, No.2, p.250-258, 2015
doi:10.4149/neo_2015_030
Price: free access
[View Abstract]


Pre- and post-operative evaluation: percentages of circulating myeloid-derived suppressor cells in rectal cancer patients
Authors: L. YUAN, B. XU, H. FAN, P. YUAN, P. ZHAO, Z. SUO
Neoplasma Vol.62, No.2, p.239-249, 2015
doi:10.4149/neo_2015_029
Price: free access
[View Abstract]


Genome-wide pathway analysis in glioma
Authors: Y. H. LEE, G. G. SONG
Neoplasma Vol.62, No.2, p.230-238, 2015
doi:10.4149/neo_2015_028
Price: free access
[View Abstract]


Autophagy inhibitor sensitizes MCF-7 breast cancer cells to novel cyclic tetrapeptide CTS203-induced caspase-9-dependent apoptotic cell death
Authors: S. WANG, X. LI, Q. WANG, Z. XIU
Neoplasma Vol.62, No.2, p.220-229, 2015
doi:10.4149/neo_2015_027
Price: free access
[View Abstract]


Inhibitory effects of indirubin derivative PHII-7 on invasion and migration in metastatic cancer
Authors: X. GAO, Y. ZHOU, K. X. WU, Y. H. DING, D. M. FAN, M. YANG, Y. Z. ZHANG, Y. J. ZHANG, D. S. XIONG
Neoplasma Vol.62, No.2, p.209-229, 2015
doi:10.4149/neo_2015_026
Price: free access
[View Abstract]


Autophagy facilitates multidrug resistance development through inhibition of apoptosis in breast cancer cells
Authors: W. L. SUN, D. LAN, T. Q. GAN, Z. W. CAI
Neoplasma Vol.62, No.2, p.199-208, 2015
doi:10.4149/neo_2015_025
Price: free access
[View Abstract]


MicroRNA 363 mediated positive regulation of c-myc translation affect prostate cancer development and progress
Authors: Y. CHEN, X. LU, B. WU, Y. SU, J. LI, H. WANG
Neoplasma Vol.62, No.2, p.191-198, 2015
doi:10.4149/neo_2015_024
Price: free access
[View Abstract]


The endoplasmic reticulum stress response is associated with insulin resistance-mediated drug resistance in HepG2 cells
Authors: L. LI, G. LI, H. WEI, J. SUN, J. CHEN, B. XIE, B. WANG, J. GU, C. LI, B. TIAN, F. WANG
Neoplasma Vol.62, No.2, p.180-190, 2015
doi:10.4149/neo_2015_023
Price: free access
[View Abstract]


Sorafenib-irinotecan sequential therapy augmented the anti-tumor efficacy of monotherapy in hepatocellular carcinoma cells HepG2
Authors: Z. WANG, Z. ZHAO, T. WU, L. SONG, Y. ZHANG
Neoplasma Vol.62, No.2, p.172-179, 2015
doi:10.4149/neo_2015_022
Price: free access
[View Abstract]


Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia patients – worldwide battlefield
Authors: P. DVORAK, D. LYSAK, S. VOKURKA
Neoplasma Vol.62, No.2, p.167-171, 2015
doi:10.4149/neo_2015_021
Price: free access
[View Abstract]





Display #  
Results 81 - 100 of 120

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.